{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:24:54Z","timestamp":1776785094540,"version":"3.51.2"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijcard.2013.05.013","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T19:45:21Z","timestamp":1369683921000},"page":"1788-1794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases"],"prefix":"10.1016","volume":"168","author":[{"given":"Nitin","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.05.013_bb0005","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"267","author":"Schmidt","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0010","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/biof.1018","article-title":"An update on advanced glycation endproducts and atherosclerosis","volume":"38","author":"Del Turco","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pharmthera.2009.06.013","article-title":"RAGE, vascular tone and vascular disease","volume":"124","author":"Farmer","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tibs.2011.08.008","article-title":"RAGE: a single receptor fits multiple ligands","volume":"36","author":"Fritz","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1172\/JCI32703","article-title":"Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE\u2212\/\u2212 mice","volume":"118","author":"Harja","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0040","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0045","doi-asserted-by":"crossref","first-page":"19919","DOI":"10.1074\/jbc.274.28.19919","article-title":"Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways","volume":"274","author":"Huttunen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0055","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20030800","article-title":"The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment","volume":"198","author":"Chavakis","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1440-1681.2007.04875.x","article-title":"The AGE\/RAGE axis in diabetes-accelerated atherosclerosis","volume":"35","author":"Jandeleit-Dahm","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijcard.2010.05.075","article-title":"Serum levels of soluble receptor for advanced glycation end products (sRAGE) in Takayasu's arteritis","volume":"145","author":"Mahajan","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.atherosclerosis.2009.06.003","article-title":"Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease","volume":"207","author":"Mahajan","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":"Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0080","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.str.2010.05.017","article-title":"Structural basis for ligand recognition and activation of RAGE","volume":"18","author":"Koch","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0085","doi-asserted-by":"crossref","first-page":"40762","DOI":"10.1074\/jbc.M110.169276","article-title":"The 1.5 A crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding","volume":"285","author":"Park","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbamcr.2005.08.006","article-title":"Evaluation of rage isoforms, ligands, and signaling in the brain","volume":"1746","author":"Ding","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0095","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1096\/fj.07-9909com","article-title":"Identification, classification, and expression of RAGE gene splice variants","volume":"22","author":"Hudson","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0100","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0105","doi-asserted-by":"crossref","first-page":"35507","DOI":"10.1074\/jbc.M806948200","article-title":"Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0110","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2008.02.163","article-title":"Calcium-regulated intramembrane proteolysis of the RAGE receptor","volume":"370","author":"Galichet","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0120","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2741\/e178","article-title":"Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker","volume":"2","author":"Yamagishi","year":"2010","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MOL.0b013e32835aea13","article-title":"Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity","volume":"24","author":"Gaens","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1196\/annals.1333.081","article-title":"Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury","volume":"1043","author":"Kaneko","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF03401819","article-title":"Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs","volume":"3","author":"Stitt","year":"1997","journal-title":"Mol Med"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/heart.85.1.87","article-title":"Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients","volume":"85","author":"Kiuchi","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0145","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/diacare.24.9.1620","article-title":"Advanced glycation end products in nondiabetic patients with coronary artery disease","volume":"24","author":"Kanauchi","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.numecd.2006.09.005","article-title":"Glycated apolipoprotein B and myocardial infarction","volume":"17","author":"Misciagna","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cvr\/cvp036","article-title":"RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice","volume":"82","author":"Sun","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0160","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1177\/030006051204000527","article-title":"Circulating soluble receptor for advanced glycation end products is inversely correlated to oxidized low-density lipoproteins in asymptomatic subjects","volume":"40","author":"Kotani","year":"2012","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0165","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0175","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.10859","article-title":"High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine","volume":"48","author":"Taniguchi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0180","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.autrev.2012.03.007","article-title":"HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis","volume":"11","author":"de Souza","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.carpath.2006.11.006","article-title":"HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques","volume":"16","author":"Inoue","year":"2007","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.atherosclerosis.2008.12.016","article-title":"Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients","volume":"205","author":"Yan","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2796.2011.02369.x","article-title":"HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction","volume":"270","author":"Andrassy","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0200","doi-asserted-by":"crossref","first-page":"e52081","DOI":"10.1371\/journal.pone.0052081","article-title":"HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease","volume":"7","author":"Andrassy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0205","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1161\/CIRCULATIONAHA.108.769331","article-title":"High-mobility group box-1 in ischemia\u2013reperfusion injury of the heart","volume":"117","author":"Andrassy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbrc.2004.07.096","article-title":"S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)","volume":"322","author":"Marenholz","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00726-008-0097-7","article-title":"Human S100A12: a novel key player in inflammation?","volume":"36","author":"Pietzsch","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/icb.2009.88","article-title":"S100 calgranulins in inflammatory arthritis","volume":"88","author":"Perera","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0225","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/ATVBAHA.111.236927","article-title":"S100A8 and S100A9 in cardiovascular biology and disease","volume":"32","author":"Averill","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0230","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/ATVBAHA.109.190314","article-title":"High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions","volume":"29","author":"Ionita","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0235","doi-asserted-by":"crossref","first-page":"41521","DOI":"10.1074\/jbc.M509442200","article-title":"S100A8 and S100A9 in human arterial wall. Implications for atherogenesis","volume":"280","author":"McCormick","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0240","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/hrt.2007.121640","article-title":"Increased serum levels and expression of S100A8\/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina","volume":"94","author":"Miyamoto","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0245","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00726-010-0528-0","article-title":"Inflammation-associated S100 proteins: new mechanisms that regulate function","volume":"41","author":"Goyette","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaci.2006.08.021","article-title":"S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity","volume":"119","author":"Yang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0255","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.1000863","article-title":"Complement C3a, CpG oligos, and DNA\/C3a complex stimulate IFN-alpha production in a receptor for advanced glycation end product-dependent manner","volume":"185","author":"Ruan","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0260","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","article-title":"Septic shock is associated with receptor for advanced glycation end products ligation of LPS","volume":"186","author":"Yamamoto","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0265","doi-asserted-by":"crossref","first-page":"e20132","DOI":"10.1371\/journal.pone.0020132","article-title":"Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice","volume":"6","author":"Ramsgaard","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0270","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200317115","article-title":"Central role of RAGE-dependent neointimal expansion in arterial restenosis","volume":"111","author":"Sakaguchi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0275","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y","article-title":"Role of receptor for advanced glycation end-product (RAGE) and the JAK\/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells","volume":"81","author":"Huang","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0280","doi-asserted-by":"crossref","first-page":"38635","DOI":"10.1074\/jbc.M202515200","article-title":"Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation","volume":"277","author":"Huttunen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0285","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M801465200","article-title":"Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42","volume":"283","author":"Hudson","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(03)00846-9","article-title":"The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site","volume":"550","author":"Ishihara","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0295","doi-asserted-by":"crossref","first-page":"e23132","DOI":"10.1371\/journal.pone.0023132","article-title":"TIRAP, an adaptor protein for TLR2\/4, transduces a signal from RAGE phosphorylated upon ligand binding","volume":"6","author":"Sakaguchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0300","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","article-title":"Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction","volume":"54","author":"Packard","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0310","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/db07-1808","article-title":"Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes","volume":"57","author":"Soro-Paavonen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0315","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.ATV.0000131783.74034.97","article-title":"Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study","volume":"24","author":"Burke","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0320","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/01.ATV.0000249630.02085.12","article-title":"Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes","volume":"26","author":"Cuccurullo","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0325","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","article-title":"RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy","volume":"162","author":"Wendt","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0330","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI18058","article-title":"Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily","volume":"114","author":"Bierhaus","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0335","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0340","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.numecd.2008.03.004","article-title":"Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist\/hip ratio in the general population","volume":"19","author":"Norata","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0350","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijcard.2009.01.008","article-title":"C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin","volume":"142","author":"Mahajan","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0355","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000234904.43861.f7","article-title":"C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells","volume":"48","author":"Zhong","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0360","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2003.08.021","article-title":"The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages","volume":"171","author":"Hasegawa","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0365","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2337\/diabetes.47.7.1155","article-title":"Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups","volume":"47","author":"Hudson","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","article-title":"RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response","volume":"3","author":"Hofmann","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0375","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bbamcr.2008.11.016","article-title":"Binding of S100 proteins to RAGE: an update","volume":"1793","author":"Leclerc","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0380","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5414\/CNP73044","article-title":"Relation between polymorphisms of receptor for advanced glycation end products (RAGE) and cardiovascular diseases in Chinese patients with diabetic nephropathy","volume":"73","author":"Poon","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0385","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/diabetes.52.3.891","article-title":"The functional -374 T\/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients","volume":"52","author":"Pettersson-Fernholm","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0390","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.metabol.2006.09.013","article-title":"Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans","volume":"56","author":"Jang","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0395","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2337\/diabetes.50.6.1505","article-title":"Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy","volume":"50","author":"Hudson","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0400","doi-asserted-by":"crossref","first-page":"e50790","DOI":"10.1371\/journal.pone.0050790","article-title":"Meta-analysis of RAGE gene polymorphism and coronary heart disease risk","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0405","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension","volume":"23","author":"Geroldi","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.metabol.2008.10.020","article-title":"Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients","volume":"58","author":"Nakamura","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0415","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MCA.0b013e32834f114e","article-title":"Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients","volume":"23","author":"Yoon","year":"2012","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijcard.2012.04.134","article-title":"Potential biomarkers for disease activity in Takayasu's arteritis","volume":"158","author":"Mahajan","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0425","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.arcmed.2012.07.007","article-title":"Extracellular matrix remodeling in Takayasu's arteritis: role of matrix metalloproteinases and adventitial inflammation","volume":"43","author":"Mahajan","year":"2012","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2005.11.101","article-title":"Role of C-C chemokines in Takayasu's arteritis disease","volume":"112","author":"Dhawan","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2013.01.002","article-title":"Receptor for advanced glycation end products (RAGE), inflammatory ligand EN-RAGE and soluble RAGE (sRAGE) in subjects with Takayasu's arteritis","author":"Mahajan","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0440","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijcard.2009.09.557","article-title":"Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease","volume":"145","author":"Mahajan","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0445","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0450","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9149(94)90446-4","article-title":"Fate of coronary arterial aneurysms in Kawasaki disease","volume":"74","author":"Suzuki","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0455","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0140-6736(03)12986-8","article-title":"S100A12 (EN-RAGE) in monitoring Kawasaki disease","volume":"361","author":"Foell","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0460","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1002\/art.23042","article-title":"Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12","volume":"56","author":"Wittkowski","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0465","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/pr.2012.27","article-title":"Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease","volume":"71","author":"Gong","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0470","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1186\/ar4094","article-title":"Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease","volume":"14","author":"Qi","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0475","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/rheumatology\/kem215","article-title":"Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus","volume":"46","author":"de Leeuw","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0480","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203306069972","article-title":"Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus","volume":"15","author":"de Leeuw","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0485","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar3332","article-title":"High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus","volume":"13","author":"Abdulahad","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0490","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/0961203312444495","article-title":"Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis","volume":"21","author":"Martens","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2013.05.013_bb0495","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/rheumatology\/ken302","article-title":"Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts","volume":"47","author":"Nienhuis","year":"2008","journal-title":"Rheumatology (Oxford)"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313009224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313009224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:44:22Z","timestamp":1759092262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313009224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0167527313009224"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.05.013","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}